(Q41724677)

8 October 2017

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder (English)

1 reference

8 October 2017

1 reference

Winsberg ME

1

1 reference

8 October 2017

Sachs N

2

1 reference

8 October 2017

Tate DL

3

1 reference

8 October 2017

Adalsteinsson E

4

1 reference

8 October 2017

Spielman D

5

1 reference

8 October 2017

Ketter TA

6

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

8 October 2017

Biological Psychiatry

1 reference

8 October 2017

47

1 reference

8 October 2017

475-481

1 reference

8 October 2017

6

1 reference

A classification of hand preference by association analysis

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Quantitative in vivo 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

N-acetylaspartate in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

Rapid, fully automatic, arbitrary-volume in vivo shimming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900183-3

10.1016/S0006-3223(99)00183-3

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference